학술논문

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, February 2022, 23(2):248-258)
Subject
Language
English
ISSN
14745488
14702045